Short Interest in JanOne Inc. (NASDAQ:JAN) Declines By 41.0%

JanOne Inc. (NASDAQ:JAN) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 147,800 shares, a decrease of 41.0% from the March 31st total of 250,500 shares. Based on an average daily volume of 304,300 shares, the days-to-cover ratio is presently 0.5 days.

JanOne Stock Down 1.5 %

Shares of NASDAQ JAN opened at $4.71 on Friday. The firm’s fifty day moving average is $2.54 and its 200 day moving average is $1.21. JanOne has a 52 week low of $0.22 and a 52 week high of $5.08.

About JanOne

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments.